These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11602149)

  • 1. [Severe pulmonary hypertensión treated with low dose carvedilol in a patient infected with the human immunodeficiency virus].
    Eulalia Valencia M; Guinea J; Moreno V; González-Lahoz J
    Enferm Infecc Microbiol Clin; 2001 Oct; 19(8):412-3. PubMed ID: 11602149
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary hypertension in patients with human immunodeficiency virus infection. Study of 14 cases].
    Valencia Ortega ME; Ortega Millán G; Guinea Esquerdo J; Laguna Cuesta F; Moreno Celda V; Gónzalez Lahoz J
    Med Clin (Barc); 2000 Jul; 115(5):181-4. PubMed ID: 10996875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of carvedilol: a preliminary dose-response study.
    Casadei B; Conway J; Coats AJ; Bird R
    Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach.
    Stienen U; Meyer-Sabellek W
    Clin Investig; 1992; 70 Suppl 1():S65-72. PubMed ID: 1350487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MUCHA(Multicenter Carvedilol Heart Failure Dose Assessment Trial)].
    Aoyama N
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():526-30. PubMed ID: 17508586
    [No Abstract]   [Full Text] [Related]  

  • 7. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
    Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
    Vasil'ev AP; Strel'tsova NN; Gorbunova TIu
    Kardiologiia; 2003; 43(2):69-70. PubMed ID: 12913988
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Flack JM
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):664-5. PubMed ID: 20928961
    [No Abstract]   [Full Text] [Related]  

  • 11. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertension.
    Bakris GL; Weber MA
    Rev Cardiovasc Med; 2008; 9(2):96-105. PubMed ID: 18660730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New indications for beta blockers. Cave hypertension focus/heart failure].
    MMW Fortschr Med; 2000 Jan; 142(1-2):52-3. PubMed ID: 11294191
    [No Abstract]   [Full Text] [Related]  

  • 14. Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
    Maekawa M; Takahashi A; Miki Y
    Ther Apher Dial; 2017 Oct; 21(5):513-514. PubMed ID: 28524584
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
    Shimamoto K; Kawana M
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
    [No Abstract]   [Full Text] [Related]  

  • 16. Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
    Souza FC; Neri JS; Marques EB; Barros RB; Scaramello CB
    Int J Cardiol; 2015 Jul; 191():4-6. PubMed ID: 25957928
    [No Abstract]   [Full Text] [Related]  

  • 17. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with carvedilol is associated with a significant reduction in microalbuminuria: a multicentre randomised study.
    Fassbinder W; Quarder O; Waltz A
    Int J Clin Pract; 1999; 53(7):519-22. PubMed ID: 10692737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.